chr10-93062160-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PM5BP4
The NM_183374.3(CYP26C1):āc.355C>Gā(p.Gln119Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000576 in 1,388,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q119P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_183374.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP26C1 | NM_183374.3 | c.355C>G | p.Gln119Glu | missense_variant | 2/6 | ENST00000651965.1 | NP_899230.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP26C1 | ENST00000651965.1 | c.355C>G | p.Gln119Glu | missense_variant | 2/6 | NM_183374.3 | ENSP00000498424 | P1 | ||
CYP26C1 | ENST00000624358.3 | c.355C>G | p.Gln119Glu | missense_variant, NMD_transcript_variant | 2/6 | 2 | ENSP00000485098 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000290 AC: 4AN: 137776Hom.: 0 AF XY: 0.0000270 AC XY: 2AN XY: 74140
GnomAD4 exome AF: 0.00000576 AC: 8AN: 1388186Hom.: 0 Cov.: 32 AF XY: 0.00000584 AC XY: 4AN XY: 685128
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 01, 2024 | The c.355C>G (p.Q119E) alteration is located in exon 2 (coding exon 2) of the CYP26C1 gene. This alteration results from a C to G substitution at nucleotide position 355, causing the glutamine (Q) at amino acid position 119 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at